Stay up-to-date with the latest news and information from the drug testing industry by subscribing to Results, our monthly newsletter.
Your Privacy Choices | Privacy Notices | Privacy Shield | Terms | Language Assistance / Non-Discrimination Notice | Asistencia de Idiomas / Aviso de no Discriminación | 語言協助 / 不䈚視通知
Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks — ® and ™ — are the property of their respective owners. © 2000-2023 Quest Diagnostics Incorporated. All rights reserved.
Earlier this month, the Office of Drug and Alcohol Policy and Compliance (ODAPC) issued an official Question & Answer document that clarifies collector guidelines outlined in 49 CFR Part 40. Specifically, the document addresses when a collector can give a donor permission to leave the collection site, and what a collector should do if a donor leaves the collection site prior to the completion of the collection.
To review the revised guidelines, click here to visit the ODAPC website.
For more information about drug testing, visit our website.